Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelines

Cytometry B Clin Cytom. 2021 Jul;100(4):402-405. doi: 10.1002/cyto.b.21960. Epub 2020 Oct 3.

Authors

Lori E Lowes¹, Benjamin D Hedley¹, D Robert Sutherland², Michael Keeney¹

Affiliations

¹ Pathology and Laboratory Medicine, London Health Sciences Centre, London, Ontario, Canada.
² Laboratory Medicine Program, The University Health Network, Toronto, Ontario, Canada.

PMID: 33009886
DOI: 10.1002/cyto.b.21960

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD34 / blood*
Antigens, CD34 / isolation & purification
Cell Lineage / genetics
Erythrocytes / cytology
Flow Cytometry / methods*
Hematologic Neoplasms / blood*
Hematologic Neoplasms / pathology
Humans
Peripheral Blood Stem Cells / cytology*

Substances

Antigens, CD34